Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
419 JPY | +1.45% | -3.01% | -40.31% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.31% | 182M | |
-1.92% | 103B | |
+0.84% | 95.71B | |
+1.69% | 22.02B | |
-17.03% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.03% | 15.52B | |
+3.61% | 13.86B | |
+34.81% | 12.04B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- SanBio Signs $9 Million Credit Line Agreement to Fund Brain Injury Support Program